Coleman M D, Adjepon-Yamoah K K
Biochem Pharmacol. 1986 Oct 1;35(19):3389-92. doi: 10.1016/0006-2952(86)90440-5.
We have investigated the disposition of suramin in the isolated perfused rat liver preparation (IPRL) after the administration of suramin (18 mg, 8 muCi). At 30 min post drug administration, almost 100% of the [14C]radioactivity and unchanged suramin were located in the perfusate plasma. During the course of the study, the elimination of suramin from the IPRL was barely perceptible. The AUC0-5 hr of suramin (730.6 +/- 86.2 micrograms hr/ml) corresponded to that of [14C] radioactivity (815.1 +/- 105.5 micrograms ml/hr) at 5 hr, indicating a lack of perfusate suramin metabolites. At 5 hr only a small proportion of [14C] radioactivity was recovered from the livers (2.5 +/- 1.1%). Subsequent HPLC analysis of the liver tissue indicated this to be unchanged suramin. Sub-cellular fractionation of the homogenised livers revealed suramin to be distributed in the liposomal rich tissue fractions (10,000 g pellet, 1.6 +/- 0.8%; 105,000 g supernatant, 1.1 +/- 0.35%). Biliary excretion of [14C] radioactivity was low (2.1 +/- 0.7%), however, none could be accounted for as unchanged suramin. Previously undetected metabolites of suramin may have accounted for the unidentified biliary radioactivity.
我们研究了给予苏拉明(18毫克,8微居里)后,苏拉明在离体灌注大鼠肝脏制剂(IPRL)中的处置情况。给药后30分钟,几乎100%的[14C]放射性和未变化的苏拉明位于灌注液血浆中。在研究过程中,IPRL中苏拉明的消除几乎难以察觉。苏拉明的0至5小时药时曲线下面积(AUC0-5 hr)(730.6±86.2微克·小时/毫升)与5小时时[14C]放射性的AUC(815.1±105.5微克·毫升/小时)相对应,表明灌注液中不存在苏拉明代谢产物。5小时时,仅从肝脏中回收了一小部分[14C]放射性(2.5±1.1%)。随后对肝脏组织进行的高效液相色谱分析表明,这是未变化的苏拉明。对匀浆肝脏进行亚细胞分级分离显示,苏拉明分布在富含脂质体的组织部分(10,000克沉淀,1.6±0.8%;105,000克上清液,1.1±0.35%)。[14C]放射性的胆汁排泄量较低(2.1±0.7%),然而,没有任何一部分可归因于未变化的苏拉明。苏拉明以前未检测到的代谢产物可能是未鉴定的胆汁放射性的原因。